Vice Chairman of SG Cowen, Stelios Papadopoulos, focuses on the biotechnology and pharmaceutical sectors of the economy. Dr. Papadopoulos highlights financial innovations in biotechnology aimed at reconciling the conflict between the need to invest aggressively in research as well as the expectation to maintain a profit picture attractive to investors. (#7822)